Research Article

Gliclazide Does Not Fully Prevent 2-Deoxy-D-Ribose-Induced Oxidative Damage Because It Does Not Restore Glutathione Content in a Pancreatic β-Cell Line

Table 1

Percentage of annexin V-positive cells in vehicle- and dRib-treated HIT-T15 cells, with or without gliclazide or NAC.

Annexin V-positive cells (%)

Control
50 mM dRib alone **
10 μM gliclazide + 50 mM dRib
50 μM gliclazide + 50 mM dRib
100 μM gliclazide + 50 mM dRib ††
1 mM NAC + 50 mM dRib ††

Group data from the experiments illustrated in Figure 2 are expressed as the mean ± SD of four independent experiments. ** versus control (0.04% DMSO) and and †† versus 50 mM dRib group evaluated by one-way ANOVA with Duncan’s post hoc test.